Quick Guide to Oncology & Hematology

Caidya partners with biopharma innovators to bring clarity and confidence to oncology and hematology drug development. With flexible trial design and agile execution, we accelerate timelines while maintaining precision and quality. Our scalable approach and strong global footprint allow us to seamlessly navigate the evolving landscape of oncology and hematology research—supporting both regional and global needs with the speed and adaptability today’s trials demand.

Leading a new way

The latest from Caidya

Explore our news and updates as we deliver a superior customer experience.

02/17/2026

Caidya Names Michael Clay COO to Drive Operational Excellence and Advance Multi-Regional Clinical Development

RALEIGH, N.C.; February 17, 2026 – Caidya, a leading global,...

02/10/2026

Caidya Strengthens European Growth Strategy and Appoints Mario Bautista as Head of Business Development, Europe

RALEIGH, N.C.; Feb 10, 2026 – Caidya, a leading global, mid-sized CRO focused on accelerating...

12/19/2025

Caidya’s Miles Pan Named to Legal 500 GC Powerlist China 2025

RALEIGH, N.C. and SHANGHAI, CHINA; December 19, 2025 – Caidya,...
Skip to toolbar